FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


19439 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Acute lymphoblastic leukemia, L2 type Precursor cell lymphoblastic leukemia
Acute mastoiditis with other complications Acute mastoiditis with complication
Acute mastoiditis without complications Acute mastoiditis (disorder)
Acute mastoiditis without complications Acute mastoiditis (disorder)
Acute monoblastic and monocytic leukemia Acute monocytic leukemia
Acute monoblastic leukemia Acute monocytic leukemia
Acute monoblastic leukemia in remission Acute monocytic leukemia in remission
Acute monocytic leukemia, FAB M5 Acute monocytic leukemia
Acute monocytic/monoblastic leukemia Acute monocytic leukemia
Acute myelogenous leukemia with maturation, FAB M2 Acute myeloid leukemia with maturation, FAB M2
Acute myeloid leukemia - category Acute myeloid leukemia (morphologic abnormality)
Acute myeloid leukemia due to recurrent genetic abnormality Acute myeloid leukemia, disease
Acute myeloid leukemia with FMS-like tyrosine kinase-3 mutation Acute myeloid leukemia, disease
Acute myeloid leukemia with FMS-like tyrosine kinase-3 mutation Acute myeloid leukemia (morphologic abnormality)
Acute myeloid leukemia with multilineage dysplasia following a myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative disorder Acute myeloid leukemia (morphologic abnormality)
Acute myeloid leukemia with multilineage dysplasia without antecedent myelodysplastic syndrome Acute myeloid leukemia (morphologic abnormality)
Acute myeloid leukemia with mutated RUNX1 Acute myeloid leukemia with RUNX1::RUNX1T1 fusion
Acute myeloid leukemia with recurrent genetic abnormality Acute myeloid leukemia (morphologic abnormality)
Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL Acute myeloid leukemia with KMT2A rearrangement (morphologic abnormality)
Acute myeloid leukemia, no International Classification of Diseases for Oncology subtype Acute myeloid leukemia (morphologic abnormality)
Acute myelomonocytic leukemia - eosinophilic variant Acute myeloid leukemia with CBFB::MYH11 fusion (disorder)
Acute myoendocarditis NOS Acute myoendocarditis
Acute necrotizing encephalitis, NEC Acute necrotizing encephalitis
Acute non-A non-B hepatitis Acute viral hepatitis
Acute non-A, non-B, non-C hepatitis Acute viral hepatitis
Acute osteomyelitis NOS Acute osteomyelitis (disorder)
Acute osteomyelitis NOS Acute osteomyelitis (disorder)
Acute parametritis and pelvic cellulitis Acute pelvic inflammatory disease
Acute pelvic cellulitis Acute pelvic inflammatory disease
Acute pelvic inflammatory disease NOS Acute pelvic inflammatory disease
Acute pelvic inflammatory disease NOS Acute pelvic inflammatory disease
Acute peptic ulcer NOS Acute peptic ulcer
Acute peptic ulcer NOS Acute peptic ulcer
Acute pharyngitis, NOS Acute pharyngitis
Acute pneumothorax NOS Acute pneumothorax
Acute polyarticular juvenile rheumatoid arthritis Acute polyarticular juvenile idiopathic arthritis (disorder)
Acute polyarticular juvenile rheumatoid arthritis Acute polyarticular juvenile idiopathic arthritis (disorder)
Acute reaction to foreign substance left during procedure NOS Acute reaction to foreign substance left during procedure
Acute renal failure due to obstruction Post-renal acute kidney injury
Acute respiratory distress, NEC Acute respiratory distress (finding)
Acute respiratory infection NOS Acute respiratory infections
Acute rheumatic heart disease, NOS Acute rheumatic heart disease
Acute suppurative otitis media due to another disease Acute suppurative otitis media
Acute yellow atrophy of liver during pregnancy Necrosis of liver of pregnancy
Acyclovir 200mg dispersible tablet Aciclovir 200 mg oral tablet
Acyclovir 400mg dispersible tablet Aciclovir 400 mg oral tablet
Acyclovir 800mg dispersible tablet Aciclovir 800 mg oral tablet
Addiction Addiction
Addison's disease, NOS Addison's disease
Additional general conditions of patient Clinical finding (finding)
Additional preoperative procedure instituted by anesthetist Preoperative procedure
Additional preoperative therapy instituted by anesthetist Preoperative procedure
Adductor digiti minimi muscle of hand Structure of abductor digiti minimi muscle of hand (body structure)
Adenocarcinoid tumor Well-differentiated neuroendocrine tumor (morphologic abnormality)
Adenocarcinoid tumour Well-differentiated neuroendocrine tumor (morphologic abnormality)
Adenocarcinoma and squamous carcinoma histologic grade Histologic grade of neoplasm (observable entity)
Adenocarcinoma, no subtype Adenocarcinoma (morphologic abnormality)
Adenocarcinoma, no subtype, high grade High grade adenocarcinoma (morphologic abnormality)
Adenocarcinoma, no subtype, intermediate grade Intermediate grade adenocarcinoma (morphologic abnormality)
Adenocarcinoma, no subtype, low grade Low grade adenocarcinoma (morphologic abnormality)
Adenofibroma, no International Classification of Diseases for Oncology subtype Benign adenofibroma (morphologic abnormality)
Adenoma, no subtype Adenoma (morphologic abnormality)
Adenosine 3mg/mL infusion solution 10mL vial Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for injection (clinical drug)
Adhesiolysis - action Dissection - action
Adjustment of external splintage Adjusting of splint
Adjustment reaction in infancy Adjustment reaction in infancy (disorder)
Adjustment reaction of adolescence Adjustment reaction of adolescence (disorder)
Adjustment reaction of adult life Adjustment reaction of adult life (disorder)
Adjustment reaction of childhood Adjustment reaction of childhood (disorder)
Adjustment reaction of late life Adjustment reaction of late life (disorder)
Adjustment to prosthesis in organ NOC Prosthetic readjustment
Adjustments to denture by other than dentist providing appliances Adjust denture
Administration Introduction procedure (procedure)
Administration Introduction procedure (procedure)
Administration Introduction procedure (procedure)
Administration Introduction procedure (procedure)
Administration of RhD immune globulin Administration of human anti-D immunoglobulin (procedure)
Administration of RhD immune globulin declined Administration of human anti-D immunoglobulin declined
Administration of anesthesia for obstetric procedure Administration of anesthesia (procedure)
Administration of anesthesia for procedure Administration of anesthesia (procedure)
Administration of prescribed medications and solutions Administration of medication
Administration of prescribed medications based on arterial blood gas results Administration of medication
Administration of skin test by nurse Skin test
Administration of substance Introduction procedure (procedure)
Administration of substance by intravenous piggyback Administration via intravenous route (procedure)
Administration of substance into bladder via intravesical route Administration into urinary bladder via intravesical route
Administration of substance via enteral route Administration via enteral route (procedure)
Administration of substance via gastroenteral route Administration via gastroenteral route
Administration of substance via intraarterial route Administration via intraarterial route
Administration of substance via intravenous route Administration via intravenous route (procedure)
Administration of substance via oral route Administration via oral route (procedure)
Administration of substance via specific route Administration via specific route
Administration of substance via subcutaneous route Administration via subcutaneous route
Administration of substance via topical route Administration via topical route
Administration of substance via vaginal route Medication administration: vaginal
Administration of syntometrine Administration of ergometrine and oxytocin
Administration of therapeutic medication Administration of medication
Administration of therapeutic substance Administration of medication
Administration of therapeutic substance Administration of medication
Administration of therapeutic substance into artery Administration via intraarterial route
Administration of vaccine product containing only Human papillomavirus 9 antigen Administration of Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine

Start Previous Page 5 of 195 Next End


Reference Sets

Reference set descriptor

Back to Start